News and Trends 23 Aug 2022
Freedom Biosciences exits stealth with $10.5M financing to develop mental health treatments
Freedom Biosciences, a U.S. clinical-stage biotech platform developing ketamine and psychedelic therapeutics, today emerged from stealth with $10.5 million in seed financing. MBX Capital led the round and was joined…